Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety
-
Published:2022-12
Issue:12
Volume:121
Page:2430-2437
-
ISSN:0929-6646
-
Container-title:Journal of the Formosan Medical Association
-
language:en
-
Short-container-title:Journal of the Formosan Medical Association
Author:
Shao Yu-YunORCID,
Feng Yin-Hsun,
Yen Chia-Jui,
Yang Tsai-Sheng,
Shen Ying-Chun,
Chao Yee,
Chen Jen-Shi,
Su Ching-Yen,
Chen Wei-Jen,
Hsiang Hwa-Lin,
Hsu Chih-Hung
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献